An enzymatic method for erythrocyte acetylcholinesterase.

Prior research has established methods for measuring acetylcholinesterase in various biological samples. However, a precise and reliable approach for erythrocyte acetylcholinesterase remains limited. Established techniques often rely on acetylthiocholine substrates, which may not fully capture the enzymatic behavior of acetylcholine. No prior work had resolved the need for a choline-specific assay that avoids interference from other compounds. This gap motivated the development of a new enzymatic method. The study introduces a choline oxidase-based system with phenol and aminoantipyrene to detect choline. This approach aims to improve accuracy and precision in measuring erythrocyte acetylcholinesterase activity. The method's design addresses limitations in existing protocols by incorporating a timed reaction and a linear standard curve.

The aim of this work is to develop and validate a new enzymatic method for measuring erythrocyte acetylcholinesterase activity. The specific problem addressed is the lack of a precise and interference-free assay for this enzyme in red blood cells. The researchers propose that using choline oxidase with a colorimetric endpoint will provide a more reliable alternative to traditional methods. The motivation stems from the need for accurate enzyme activity measurements in clinical and research settings. The method's design includes a timed reaction and a calibration standard to ensure reproducibility. The study also evaluates the assay's accuracy and precision across multiple batches and time frames. The goal is to provide a validated protocol that can be used in diagnostic and research applications. The findings will help improve the reliability of erythrocyte acetylcholinesterase measurements.

The method uses a 61-fold dilution of erythrocytes in water to measure acetylcholinesterase activity. The reaction occurs in a 20-minute incubation at 37 degrees Celsius. During this time, the enzyme hydrolyzes acetylcholine into choline. Choline is then detected using choline oxidase and peroxidase. The reaction produces a pink product from phenol and aminoantipyrene. The absorbance is measured at 500 nm. A choline iodide standard is included in each batch of up to 19 samples. The assay includes a calibration curve to ensure accurate quantification of enzyme activity.

The standard curve for the assay is linear up to threefold the normal enzyme activity. Between-batch precision was measured at 0.40 kU/L with a mean of 11.5 kU/L (CV 3.5%). Long-term precision over 10 months showed a variation of 0.71 kU/L at a mean of 11.7 kU/L (CV 6.1%). The method correlates well with an acetylthiocholine procedure (y = 1.02x - 0.27 kU/L, r = 0.991). Accuracy was assessed using specific inhibitors and excess erythrocyte solution. The timed reaction at 37 degrees Celsius ensured consistent choline production. The use of phenol and aminoantipyrene allowed clear detection of the pink product at 500 nm. The inclusion of a choline iodide standard in each batch improved reproducibility.

The authors propose that the new enzymatic method provides a reliable and accurate way to measure erythrocyte acetylcholinesterase activity. The study demonstrates that the method is linear up to threefold the normal enzyme activity. Between-batch and long-term precision are within acceptable ranges for clinical use. The correlation with an acetylthiocholine procedure supports the validity of the new method. The use of choline oxidase and a colorimetric endpoint improves detection specificity. The inclusion of a choline iodide standard in each batch ensures consistent calibration. The timed reaction at 37 degrees Celsius enhances reproducibility. The findings suggest that this method can be used in both research and diagnostic settings.